292 related articles for article (PubMed ID: 34221052)
1. The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
J Res Med Sci; 2021; 26():23. PubMed ID: 34221052
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R; Woolley J; Patel G; Calasans-Maia MD; Yates J
Br J Oral Maxillofac Surg; 2022 Feb; 60(2):e216-e230. PubMed ID: 35115201
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: a systematic review.
Sacco R; Umar G; Guerra RC; Akintola O
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):648-660. PubMed ID: 34023155
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
[TBL] [Abstract][Full Text] [Related]
5. Microsurgical Reconstruction of the Jaws Using Vascularised Free Flap Technique in Patients with Medication-Related Osteonecrosis: A Systematic Review.
Sacco R; Sacco N; Hamid U; Ali SH; Singh M; Blythe JSJ
Biomed Res Int; 2018; 2018():9858921. PubMed ID: 29977926
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
Kuroshima S; Sasaki M; Murata H; Sawase T
Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
[TBL] [Abstract][Full Text] [Related]
7. The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature.
Sacco R; Akintola O; Sacco N; Acocella A; Calasans-Maia MD; Maranzano M; Olate S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241200
[No Abstract] [Full Text] [Related]
8. Is it safe to place implants in patients at risk of MRONJ?
Owen B; Bradley H
Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
[TBL] [Abstract][Full Text] [Related]
9. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
10. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
Sacco R; Ball R; Barry E; Akintola O
Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
13. Medication-related osteonecrosis of the jaw: A literature review.
Kuroshima S; Sasaki M; Sawase T
J Oral Biosci; 2019 Jun; 61(2):99-104. PubMed ID: 31109863
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
Yanni A; Bouland C; Monteiro R; Rodriguez A; Loeb I; Javadian R; Dequanter D
J Int Soc Prev Community Dent; 2022; 12(5):564-570. PubMed ID: 36532328
[TBL] [Abstract][Full Text] [Related]
16. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
17. Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.
Erovigni F; Gambino A; Cabras M; Fasciolo A; Bianchi SD; Bellini E; Fusco V
Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563481
[TBL] [Abstract][Full Text] [Related]
18. Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients-A Systematic Review.
Rosales HD; Garcia Guevara H; Requejo S; Jensen MD; Acero J; Olate S
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835951
[TBL] [Abstract][Full Text] [Related]
19. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
Muttanahally KS; Tadinada A
Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.
Gaudin E; Seidel L; Bacevic M; Rompen E; Lambert F
J Clin Periodontol; 2015 Oct; 42(10):922-32. PubMed ID: 26362756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]